Disruptive technology for individual disease profiling
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Presentation
- By: SAVIO, Eduardo (Uruguayan Centre For Molecular Imaging, Head of Radiopharmacy R&D, Montevideo, Uruguay)
- Co-author(s): Eduardo Savio:Head of Radiopharmacy R&D,Uruguayan Centre For Molecular Imaging,Montevideo,Uruguay
The diagnosis of dementia, along with the prediction of who will develop dementia has been assisted by MRI and PET. Alzheimer's disease (AD) is a major public health problem affecting nearly 35 million people worldwide.
While AD is the most common cause of dementia in the elderly, many other causes of dementia can mimic and overlap with AD.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.